PremiumCompany AnnouncementsSanuwave Health Cancels Merger and Issues Press Release Sanuwave Health Advances Merger Amid Financial Restructuring Sanuwave Health sees Q1 revenue $5.7M-$5.9, up 51%-56% over 1Q23 PremiumMarket NewsSanuwave Health Secures Funding with Asset-Backed Notes Sanuwave Health announces special meeting to vote on business combination Sanuwave Health sees Q4 revenue $6.6M-$6.8M, up 20% y/y PremiumThe FlySanuwave Health reports FY22 EPS (2c) vs (5c) last year Sanuwave Health commences trading on the OTCQB